China Pharma Holdings (CPHI) Total Current Liabilities (2010 - 2026)

China Pharma Holdings' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $7.3 million for Q1 2026.

• Quarterly Total Current Liabilities rose 41.89% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (up 41.89% YoY) and the FY2025 annual result came in at $7.4 million, up 47.5% from the prior year.
• Total Current Liabilities was $7.3 million for Q1 2026 at China Pharma Holdings, down from $7.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $12.7 million in Q4 2022 and bottomed at $4.7 million in Q2 2024.
• A 5-year average of $7.8 million and a median of $7.1 million in 2023 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2024 — Total Current Liabilities sank 55.32% — and 2025, when it jumped 47.5%.
• China Pharma Holdings' Total Current Liabilities stood at $12.7 million in 2022, then plunged by 46.46% to $6.8 million in 2023, then slipped by 26.44% to $5.0 million in 2024, then surged by 47.5% to $7.4 million in 2025, then declined by 1.79% to $7.3 million in 2026.
• Business Quant data shows CPHI's Total Current Liabilities at $7.3 million in Q1 2026, $7.4 million in Q4 2025, and $6.6 million in Q3 2025.